Sorrento Therapeutics, Inc. announced that Mr. George Uy, executive vice president and chief commercial officer, will be leaving the company at the end of July 2015 to join a start-up company as its chief executive officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0135 USD | -32.50% | -10.00% | -89.07% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-89.07% | 7.34M | |
+2.93% | 108B | |
-3.78% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- George Uy Leaves Sorrento Therapeutics, Inc. as Executive Vice President and Chief Commercial Officer